@entity420 at different positions at the gastro-oesophageal junction show distinct association with @entity3621 and gastric XXXX .

@entity1 @entity1944 @entity32 @entity5 @entity194 @entity3621 @entity1613 @entity420 @entity356
OBJECTIVE: @entity420 at the gastro-oesophageal junction (GOJ) are currently stratified by @entity5 location. This retrospective study examines the association of @entity1613 and @entity356 at different locations and compares them with nonjunctional @entity356 . @entity1 AND METHODS: A total of 520 @entity1 with junctional and nonjunctional @entity356 were assessed for the presence and degree of @entity1944 , glandular @entity194 and @entity32 in the stomach. Histopathological data were complete for 428 @entity1 (68.9% @entity1 , median age 67.7 years), including 172 @entity1 with @entity5 (GOJ1: 1-5   cm proximal to the junction, GOJ2: 'true' junctional, GOJ3: 2-5   cm distal to the junction). @entity356 and @entity1613 were scored according to the updated Sydney classification and further stratified into respective operative link on @entity3621 assessment (OLGA) and operative link on @entity3621 assessment on @entity1944 (OLGIM) stages. RESULTS: The prevalence and degree of @entity356 and @entity1944 were significantly lower in GOJ1 than GOJ3 (P<0.01). @entity1613 in the stomach were similar in GOJ3 compared with nonjunctional @entity356 . GOJ1 were almost exclusively (98.4%) of the intestinal type, whereas GOJ2 and GOJ3 were the diffuse type in 22.6 and 22.4% of the @entity1 (P<0.001). Of all @entity1 , only 8.5 and 12.7% presented with stage III/IV according to OLGA and OLGIM, respectively. However, data for OLGA and OLGIM staging were only available in 61.2 and 67.9% of @entity1 , respectively. CONCLUSION: GOJ1 are less likely to be associated with gastric pathology compared with GOJ3 or nonjunctional @entity356 . OLGA or OLGIM staging in @entity1 with @entity5 seems to be of limited value.
